荧光素辅助立体定向脑活检预测明确组织学诊断的可靠性
本研究纳入19例立体定向脑活检患者,术前MRI增强14例、非增强5例,麻醉诱导时给予3 mg/kg荧光素钠,术中Yellow560模块拍照由两名盲法观察者回顾性判定荧光状态。荧光与MRI增强病灶比较的敏感度97%、特异度40%、阳性预测值82%;与确诊肿瘤病理比较分别为100%、63%、91%。观察者间荧光状态一致性为「相当」(kappa=0.771)。
要点
- 荧光素辅助立体定向脑活检在MRI增强病灶中高概率显示荧光,敏感度97%。
- 荧光预测确诊肿瘤病理的敏感度100%、特异度63%、阳性预测值91%。
- 两名观察者荧光状态判定一致性为「相当」(kappa=0.771)。
核心结论
- 荧光素辅助立体定向脑活检在MRI增强病灶中高概率显示荧光,同时能充分预测明确的肿瘤病理。
研究设计与样本
- 研究纳入19例患者,其中术前T1钆增强MRI显示增强病灶14例、非增强病灶5例。
- 所有患者在麻醉诱导时接受3 mg/kg荧光素钠。
- 活检标本在组织病理学分析前于手术显微镜下使用Yellow560模块拍照。
- 两名对MRI扫描和组织病理学结果设盲的观察者回顾性将照片判定为「有荧光」或「无荧光」。
- 采用Cohen kappa系数评估观察者间一致性。
主要发现
- 观察者间荧光状态一致性强度为「相当」(kappa=0.771)。
- 「有荧光」与「无荧光」标本与MRI增强病灶比较的敏感度97%、特异度40%、阳性预测值82%。
- 「有荧光」与「无荧光」标本与确诊肿瘤病理比较的敏感度100%、特异度63%、阳性预测值91%。
- 永久病理显示高级别胶质瘤5例、低级别胶质瘤3例、淋巴瘤5例、松果体肿瘤2例、错构瘤1例、非特异性细胞增多3例。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to assess the reliability of fluorescein sodium in predicting conclusive tissue diagnosis in stereotactic brain biopsies and to characterize features of contrast-enhancing and non-enhancing MRI lesions associated with fluorescence. METHODS: A total of 19 patients were studied, 14 of which had contrast-enhancing and 5 of which had non-enhancing lesions on preoperative T1 post-gadolinium MRI scan. All patients received 3 mg/kg fluorescein sodium during anesthesia induction. Biopsy specimens were photographed under the operating microscope, using the Yellow560 module, prior to histopathological analysis. Two observers blinded to the MRI scans and histopathological results categorized the photographs retrospectively as "fluorescent" or "not fluorescent." Inter-rater agreement was assessed using Cohen's kappa coefficient. Sensitivity, specificity, and positive predictive value of fluorescence reliability were calculated for MRI contrast-enhancing lesions and confirmed location-concordance of tumor pathology based on rater's fluorescence status assessment. Results were correlated finally with final results on permanent sections. RESULTS: Strength of inter-rater fluorescence status agreement was found to be "substantial" (kappa = 0.771). Sensitivity, specificity, and positive predictive value for "fluorescent" and "not fluorescent" specimen in comparison with MRI contrast-enhancing lesions were 97%, 40%, and 82%, respectively. Sensitivity, specificity, and positive predictive value for confirmed tumor pathology were 100%, 63%, and 91%, respectively. Permanent pathology revealed high-grade glioma n = 5, low-grade glioma n = 3, lymphoma n = 5, pineal tumor n = 2, hamartoma n = 1, and nonspecific hypercellularity n = 3. CONCLUSIONS: Fluorescein-assisted stereotactic brain biopsies demonstrated a high likelihood to manifest fluorescence in contrast-enhancing MRI lesions, while adequately predicting conclusive tumor pathology.
引用
- Nevzati E, Chatain GP, Hoffman J, et al. Reliability of fluorescein-assisted stereotactic brain biopsies in predicting conclusive tissue diagnosis. Acta Neurochir (Wien). 2020. PMID: 32291590. doi:10.1007/s00701-020-04318-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。